Dr. Reddy’s Laboratories Ltd (BSE: 500124, NSE: DRREDDY, NYSE: RDY) announced today that it has launched Melphalan Hydrochloride for Injection, a therapeutic...
Dr. Reddy’s Laboratories Ltd. today announced its consolidated financial results for the second quarter and half year ended September 30, 2017 under...
US authorities on alleged price cartelisation by Indian generic drugmakers, have named five pharmaceutical companies including Dr. Reddy’s Laboratories, Emcure Pharmaceuticals, Glenmark...
Pharma firm Dr Reddy’s Laboratories Limited and Nasdaq-listed Integra LifeSciences Holdings Corporation today announced an exclusive distribution agreement to market and distribute...
Drug firm Dr Reddy’s Laboratories today said the US health regulator has made three observations after completing inspection of its Miryalaguda facility....
Dr. Reddy’s Laboratories Ltd announced today that it has partnered with Cykul, India’s foremost cycling company, to launch India’s largest cycle...
Dr. Reddy’s Laboratories Ltd announced today that it has entered into a strategic collaboration with Gland Pharma, a globally recognized developer and...
Dr. Reddy’s Laboratories Ltd (BSE: 500124, NSE: DRREDDY, NYSE: RDY) today announced the launch of Purple Health, a unique platform designed to...
Hyderabad based Dr.Reddy’s Laboratories is India’s 4th Most Reputed Pharmaceutical Brand as per the report by Bluebytes. While Aurobindo Pharma occupies 11th...
Dr. Reddy’s Laboratories Ltd today announced that it successfully completed the previously announced acquisitionof eight Abbreviated New Drug Applications (ANDAs) in the...